Accueil
Détail de l'auteur
Auteur P. CARRIERI |
Documents disponibles écrits par cet auteur (16)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Article : Périodique
N. KHATMI ; L. DANY ; K. NDIAYE ; P. CARRIERI ; D. ROJAS CASTRO ; P. ROUX |Background/aims: In line with Self-determination Theory, individuals who feel they are able to adopt new behaviors autonomously, and who perceive their social environment as supportive of their autonomy and confident in their competencies, are m[...]Article : Périodique
P. ROUX ; C. DONADILLE ; C. MAGEN ; E. SCHATZ ; R. STRANZ ; A. CURADO ; T. TSIAKOU ; L. VERDES ; A. ALEKSOVA ; P. CARRIERI ; S. MEZAACHE ; A. BEN CHARIF |Background: Harm reduction (HR) interventions are essential to reduce human immunodeficiency virus (HIV) and hepatitis C virus (HCV) transmission in people who inject drugs (PWID). Preliminary testing of the Individually Tailored Support and Edu[...]Article : Périodique
P. ROUX ; D. ROJAS CASTRO ; K. NDIAYE ; M. DEBRUS ; C. PROTOPOPESCU ; J. M. LE GALL ; A. HAAS ; M. MORA ; B. SPIRE ; M. SUZAN-MONTI ; P. CARRIERI |Aims: The community-based AERLI intervention provided training and education to people who inject drugs (PWID) about HIV and HCV transmission risk reduction, with a focus on drug injecting practices, other injection-related complications, and ac[...]Article : Périodique
L. MICHEL ; C. LIONS ; S. VAN MALDEREN ; J. SCHILTZ ; W. VANDERPLASSCHEN ; K. HOLM ; T. KOLIND ; F. NAVA ; N. WELTZIEN ; A. MOSER ; M. JAUFFRET-ROUSTIDE ; O. MAGUET ; P. CARRIERI ; C. BRENTARI ; H. STÖVER |BACKGROUND: Prisoners constitute a high-risk population, particularly for infectious diseases. The aim of this study was to estimate the level of infectious risk in the prisons of five different European countries by measuring to what extent the[...]Article : Périodique
Article : Périodique
H. FRASER ; N. K. MARTIN ; H. BRUMMER-KORVENKONTIO ; P. CARRIERI ; O. DALGARD ; J. DILLON ; D. GOLDBERG ; S. HUTCHINSON ; M. JAUFFRET-ROUSTIDE ; M. KABERG ; A. A. MATSER ; M. MATICIC ; H. MIDGARD ; V. MRAVCIK ; A. OVREHUS ; M. PRINS ; J. REIMER ; G. ROBAEYS ; B. SCHULTE ; D. K. VAN SANTEN ; R. ZIMMERMANN ; P. VICKERMAN ; M. HICKMAN |BACKGROUND & AIMS: Prevention of hepatitis C virus (HCV) transmission among people who inject drugs (PWID) is critical for eliminating HCV in Europe. We estimated the impact of current and scaled-up HCV treatment with and without scaling up opio[...]Article : Périodique
L. WIESSING ; M. FERRI ; V. BELACKOVA ; P. CARRIERI ; S. R. FRIEDMAN ; C. FOLCH ; K. DOLAN ; B. GALVIN ; P. VICKERMAN ; J. V. LAZARUS ; V. MRAVCIK ; M. KRETZSCHMAR ; V. SYPSA ; A. SARASA-RENEDO ; A. UUSKULA ; D. PARASKEVIS ; L. MENDAO ; D. ROSSI ; N. VAN GELDER ; L. MITCHESON ; L. PAOLI ; C. DIAZ GOMEZ ; M. MILHET ; N. DASCALU ; J. KNIGHT ; G. HAY ; E. KALAMARA ; R. SIMON ; C. M. COMISKEY ; C. ROSSI ; P. GRIFFITHS ; EUBEST working group |Background and aims: Despite advances in our knowledge of effective services for people who use drugs over the last decades globally, coverage remains poor in most countries, while quality is often unknown. This paper aims to discuss the histori[...]Article : Périodique
A. ILHAME ; C. DONADILLE ; C. PROTOPOPESCU ; D. MICHELS ; J. HERIN ; A. PLADYS ; D. BADER ; P. CARRIERI ; P. ROUX |BACKGROUND: Hepatitis C virus (HCV) infection prevalence is particularly high in people who inject drugs (PWID), a population that faces many barriers to HCV testing and care. A better understanding of the determinants of access to HCV testing i[...]Article : Périodique
T. BARRÉ ; C. RAMIER ; S. ANTWERPES ; M. COSTA ; M. BUREAU ; G. MARADAN ; V. DI BEO ; C. CUTARELLA ; J. LELOUTRE ; O. RICCOBONO-SOULIER ; S. HEDOIRE ; E. FROT ; F. VERNIER ; S. VASSAS-GOYARD ; S. DUFORT ; C. PROTOPOPESCU ; F. MARCELLIN ; D. CASANOVA ; M. COSTE ; P. CARRIERI |INTRODUCTION: Alcohol use disorder (AUD) is associated with a significant disease burden in France, where alcohol use is deeply rooted in culture. However, the treatment gap is large because of several barriers, including stigmatisation and drin[...]Article : Périodique
L. COUSIN ; G. ROUCOUX ; A. S. PETIT ; L. BAUMANN-COBLENTZ ; O. R. TORRENTE ; A. CANNAFARINA ; O. CHASSANY ; M. DURACINSKY ; P. CARRIERI |BACKGROUND: Many risk factors related to altered circadian rhythms impact the health of night-shift hospital workers (NSHW), resulting in mental and somatic disorders. Easy access to psychoactive substances (PS) may facilitate addictive behavior[...]Article : Périodique
L. MICHEL ; M. JAUFFRET-ROUSTIDE ; J. BLANCHE ; O. MAGUET ; C. CALDERON ; J. COHEN ; C. TAIEB ; P. CARRIERI ; Groupe de travail ANRS PRI²DE / ANRS PRI²DE Study group |FRANÇAIS : Introduction - En France, la prévention du risque infectieux en prison est encadrée par deux textes émanant conjointement des ministères en charge de la Justice et de la Santé : une circulaire de 1996 et un guide méthodologique actua[...]Article : Périodique
P. ROUX ; S. MEZAACHE ; L. BRIAND MADRID ; M. DEBRUS ; N. KHATMI ; G. MARADAN ; C. PROTOPOPESCU ; D. ROJAS-CASTRO ; P. CARRIERI |Aims: In France, a non-negligible proportion of opioid-dependent individuals inject morphine sulfate. Although it has not yet been officially approved as an opioid substitution treatment (OST), some physicians can prescribe its use for people in[...]Article : Périodique
P. ROUX ; M. DEBRUS ; D. ROJAS CASTRO ; F. BLADOU ; M. SUZAN-MONTI ; E. AVRIL ; P. CARRIERI |FRANÇAIS : La situation épidémiologique des usagers de drogue (UD), et tout particulièrement des UD par voie intraveineuse (UDVI), vis-à-vis du virus de l'hépatite C et du VIH appelle aujourd'hui à de nouveaux moyens de prévention et de soins. [...]NouveautéArticle : Périodique
T. BARRÉ ; V. DI BEO ; P. ROUX ; A. MOURAD ; P. VERGER ; L. FRESSARD ; T. HERAULT ; J. F. BUYCK ; F. BECK ; P. CARRIERI |Alcohol use is a leading risk factor for premature death and disability. To tackle this issue, more systematic and accurate screening for at-risk consumption is needed in healthcare systems, especially by general practitioners (GPs). We assessed[...]Article : Périodique
Purpose: People who inject drugs (PWID) face multiple health problems, including infectious diseases and drug overdoses. Applying syndemic and risk environment frameworks, this paper aims to examine the co-occurrence and clustering of drug-relat[...]